Find the right fit for you - faster
Get tailored insights about working at Fujifilm Diosynth Biotechnologies in one quick step.
Fujifilm Diosynth Biotechnologies Snapshot
At FUJIFILM Diosynth Biotechnologies our mission is to become the leading and most trusted global CDMO in the industry, and our purpose is to become Partners for Life, Advancing Tomorrow’s Medicine
FUJIFILM Diosynth Biotechnologies is a Contract Development and Manufacturing Organization (CDMO) with a team of more than 4,200 amazing employees focused on achieving our global vision – to be the leading and most trusted global Contract Development and Manufacturing Organization in the biopharmaceutical industry.
As a CDMO, we work in partnership with the most innovative biopharma and biotech companies across the world who are reimagining healthcare’s potential. We help to accelerate their progress, expand their capabilities, develop their processes, and strengthen their innovation. When our customers achieve milestones with their potential cures, vaccines, and biologics, we know our partnership and expertise helped make it happen.
Our focus is to combine technical leadership in cell culture, microbial fermentation, and cell and gene therapies with world class cGMP manufacturing facilities to advance tomorrow’s medicines.
Since 2019 we have invested more than $7 Billion USD in expansion projects at our facilities across the globe. Our growing locations increase our capabilities and expand our need for passionate, mission-driven individuals who want to make a real difference in people’s lives.
As a CDMO, we work in partnership with the most innovative biopharma and biotech companies across the world who are reimagining healthcare’s potential. We help to accelerate their progress, expand their capabilities, develop their processes, and strengthen their innovation. When our customers achieve milestones with their potential cures, vaccines, and biologics, we know our partnership and expertise helped make it happen.
Our focus is to combine technical leadership in cell culture, microbial fermentation, and cell and gene therapies with world class cGMP manufacturing facilities to advance tomorrow’s medicines.
Since 2019 we have invested more than $7 Billion USD in expansion projects at our facilities across the globe. Our growing locations increase our capabilities and expand our need for passionate, mission-driven individuals who want to make a real difference in people’s lives.
